TEVAR联合与不联合左锁骨下动脉血运重建的结局比较:基于NIS数据库的分析
本研究利用2005至2013年NIS数据库回顾性分析7,773例TEVAR患者,其中6,411例(82.5%)未行左锁骨下动脉血运重建,1,362例(17.5%)行血运重建。多因素分析显示血运重建组围术期心脏并发症、卒中和肺部并发症显著更高,但脊髓缺血与上肢缺血率相似。血运重建在TEVAR前完成较TEVAR后完成并发症更低,腔内血运重建较开放手术肺部与卒中并发症更低。
要点
- TEVAR联合LSA血运重建与围术期卒中及心肺并发症显著增加相关。
- LSA血运重建在TEVAR前完成较TEVAR后完成围术期并发症更低。
- 高危患者中腔内LSA血运重建可能优于开放手术。
核心结论
- TEVAR联合LSA血运重建与围术期卒中和心肺并发症发生率显著增加相关。
- 与TEVAR后血运重建相比,TEVAR前血运重建的围术期并发症更低。
- 在高危患者中,腔内LSA血运重建可能较开放手术更值得推荐。
研究设计与样本
- 回顾性分析Nationwide Inpatient Sample数据库2005至2013年记录。
- 共纳入7,773例TEVAR患者,6,411例(82.5%)未行LSA血运重建,1,362例(17.5%)行LSA血运重建。
- 比较采用单因素分析和多因素logistic回归,多因素模型采用前向选择法,模型进入要求P < 0.05。
- 连续变量组间比较采用t检验,分类变量采用卡方检验,所有统计分析使用R完成。
主要发现
- 两组年龄(分别为65.5 ± 15.8岁和66.1 ± 14.4岁)、性别和种族无显著差异。
- 多因素分析显示血运重建组围术期心脏并发症(OR 1.5,95% CI [1.2, 1.9],P = 0.025)、卒中(OR 2.1,95% CI [1.6, 2.8],P = 0.001)和肺部并发症(OR 1.9,95% CI [1.7, 2.3],P < 0.001)显著高于未血运重建组。
- 脊髓缺血和上肢缺血率在两组间相似。
- 1,362例血运重建患者中,1,251例(91.9%)在TEVAR前完成,111例(8.1%)在TEVAR后完成。
- 1,251例TEVAR前血运重建患者中,583例为开放手术,553例为支架置入,115例同时编码为开放和腔内。
关键数值与推荐
- 2009年Society for Vascular Surgery指南推荐血运重建发表后,TEVAR中LSA覆盖时的血运重建率翻倍。
- 多因素分析中连续协变量的OR按每标准差变化表示。
临床怎么用
- TEVAR需覆盖LSA时应权衡血运重建带来的卒中与心肺并发症风险。
- 如需血运重建,优先考虑在TEVAR前完成而非TEVAR后完成。
- 高危患者可优先选择腔内LSA血运重建而非开放手术。
局限性
- 本研究为基于NIS数据库的回顾性分析。
- 原文摘要未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare the outcomes of thoracic endovascular aortic repair (TEVAR) without and with left subclavian artery (LSA) revascularization using the Nationwide Inpatient Sample (NIS) database. METHODS: NIS records from 2005 to 2013 were retrospectively analyzed to identify patients undergoing TEVAR without and with LSA revascularization. Perioperative outcomes were compared between the two groups. The LSA revascularization group was further subdivided to compare perioperative outcomes if the revascularization was performed pre- or post-TEVAR or if the revascularization was performed open versus endovascular. Comparisons were examined using univariable analysis and multivariable logistic regression. Multivariable models were constructed using a forward selection approach with P < 0.05 required for model entry. Odds ratios are expressed per standard deviation change for continuous covariates. Continuous variables were compared between different groups using t-test, and categorical variables were compared using the chi-squared test. All statistical analyses were performed using R (cran.r-project.org). RESULTS: 7,773 TEVAR patients were included in this study. 6,411 (82.5%) were performed without and 1,362 (17.5%) with LSA revascularization. The rate of revascularization for LSA coverage during TEVAR doubled after the Society for Vascular Surgery Guidelines recommending revascularization were published in 2009. Groups were not significantly different in age (65.5 ± 15.8 and 66.1 ± 14.4 years old, respectively), gender, or race. Multivariable analysis showed that although rates of spinal cord ischemia and upper extremity ischemia were similar, perioperative cardiac complications (OR 1.5, 95% CI [1.2, 1.9], P = 0.025), stroke (OR 2.1, 95% CI [1.6, 2.8], P = 0.001), and pulmonary complications (OR 1.9, 95% CI [1.7, 2.3], P < 0.001) were significantly higher in the patients undergoing TEVAR with LSA revascularization than those without. Of the 1,362 patients with LSA revascularization, 1,251 (91.9%) were performed pre-TEVAR and 111 (8.1%) were performed post-TEVAR. Among the 1,251 patients with pre-TEVAR LSA revascularization, 583 had open surgery and 553 had stenting. In 115 patients, LSA revascularization was coded as both open and endovascular. Compared with pre-TEVAR revascularization, post-TEVAR revascularization was associated with higher risks of pulmonary complications and spinal cord ischemia. Endovascular LSA revascularization had lower pulmonary and stroke morbidity versus open LSA revascularization. The perioperative outcomes for the LSA revascularization subgroups are summarized. CONCLUSIONS: TEVAR with LSA revascularization is associated with significantly increased rates of perioperative stroke and cardiopulmonary complications. LSA revascularization before TEVAR, compared with post-TEVAR revascularization, had lower perioperative complications. In high-risk patients, endovascular LSA revascularization may be recommended over open surgery.
引用
- Delafontaine JL, Hu B, Tan TW, et al. Outcome Comparison of TEVAR with and without Left Subclavian Artery Revascularization from Analysis of Nationwide Inpatient Sample Database. Ann Vasc Surg. 2019. PMID: 30910649. doi:10.1016/j.avsg.2019.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。